Drug Injury Watch: 2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots

more+
less-

Drug Injury Watch: 2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots

Approved By FDA In 2010, There Has Been No Study Done Yet Regarding Beyaz Safety -- Despite Significant Number Of Beyaz Adverse Event Reports

http://www.drug-injury.com/druginjurycom/2012/08/beyaz-fda-report-safety-risk-blood-clots-venous-embolisms-pe-thrombosis-vein-dvt.html

LOADING PDF: If there are any problems, click here to download the file.

Published In: Personal Injury Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thomas J. Lamb, Law Offices of Thomas J. Lamb, P.A. | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »